Opus Genetics IRD Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's net gains (losses) on investments?
- Opus Genetics (IRD) reported net gains (losses) on investments of $0 in Q1 2026.
- How has Opus Genetics's net gains (losses) on investments changed year-over-year?
- Opus Genetics's net gains (losses) on investments increased by 100.0% year-over-year, from -$1K to $0.
- What is the long-term trend for Opus Genetics's net gains (losses) on investments?
- Over 2 years (2021 to 2024), Opus Genetics's net gains (losses) on investments has grown at a -56.9% compound annual growth rate (CAGR), from -$70K to -$13K.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.